AU2001247471A1 - Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones - Google Patents

Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones

Info

Publication number
AU2001247471A1
AU2001247471A1 AU2001247471A AU4747101A AU2001247471A1 AU 2001247471 A1 AU2001247471 A1 AU 2001247471A1 AU 2001247471 A AU2001247471 A AU 2001247471A AU 4747101 A AU4747101 A AU 4747101A AU 2001247471 A1 AU2001247471 A1 AU 2001247471A1
Authority
AU
Australia
Prior art keywords
polymethoxyflavones
disorders
compositions
treating
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247471A
Other languages
English (en)
Inventor
Najla Guthrie
Robert M. Horowitz
Elzbieta Maria Kurowska
John A. Manthey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KGK SYNERGIE
US Department of Agriculture USDA
Original Assignee
KGK SYNERGIE
US Department of Agriculture USDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/528,488 external-priority patent/US6987125B1/en
Application filed by KGK SYNERGIE, US Department of Agriculture USDA filed Critical KGK SYNERGIE
Publication of AU2001247471A1 publication Critical patent/AU2001247471A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001247471A 2000-03-17 2001-03-16 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones Abandoned AU2001247471A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09528488 2000-03-17
US09/528,488 US6987125B1 (en) 1998-10-06 2000-03-17 Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
PCT/US2001/008395 WO2001070029A1 (fr) 2000-03-17 2001-03-16 Composition et methodes de traitement, de diminution, et de prevention de maladies et troubles cardio-vasculaires avec des polymethoxyflavones

Publications (1)

Publication Number Publication Date
AU2001247471A1 true AU2001247471A1 (en) 2001-10-03

Family

ID=24105873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247471A Abandoned AU2001247471A1 (en) 2000-03-17 2001-03-16 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones

Country Status (4)

Country Link
EP (1) EP1278417A1 (fr)
AU (1) AU2001247471A1 (fr)
CA (1) CA2403548A1 (fr)
WO (1) WO2001070029A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987125B1 (en) 1998-10-06 2006-01-17 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
US7201928B1 (en) 1999-09-21 2007-04-10 Rutgers, The State University Of New Jersey Extracts of orange peel for prevention and treatment of cancer
CA2445963A1 (fr) * 2001-05-02 2002-11-07 Kgk Synergize Inc. Utilisation de flavones polymethoxylees afin de traiter l'insulinoresistance
EP1748773A4 (fr) * 2004-05-26 2008-11-12 Kgk Synergize Inc Aliments fonctionnels comprenant des flavonoides et des tocotrienols et procedes associes
ATE491447T1 (de) * 2004-05-26 2011-01-15 Kgk Synergize Inc Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen
JP2008513349A (ja) * 2005-05-24 2008-05-01 ケージーケー シナジャイズ インコーポレイテッド フラボノイドとトコトリエノールを含む機能性食品及びその方法
US7887852B2 (en) 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
WO2007109071A2 (fr) * 2006-03-15 2007-09-27 Rutgers, The State University Of New Jersey Compositions de polyméthoxyflavones hydroxylées
KR101340675B1 (ko) 2011-12-05 2013-12-12 대구한의대학교산학협력단 탄제레틴을 포함하는 심혈관계 질환의 예방 또는 치료용 약학 조성물
US9132117B2 (en) * 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867541A (en) * 1972-05-03 1975-02-18 Ralph C Robbins Compositions and methods for disaggregating blood cells

Also Published As

Publication number Publication date
WO2001070029A1 (fr) 2001-09-27
EP1278417A1 (fr) 2003-01-29
CA2403548A1 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AU2001243219A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU4229200A (en) Methods and compositions for treating dermatological disorders with fruit extracts
AU2001286651A1 (en) Microparticle composition and method
AUPR101600A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
AU2003212850A1 (en) Methods and compositions for treating cardiovascular disease
AU7360000A (en) Methods and compositions for preventing and treating prostate disorders
AU2002230888A1 (en) Methods and compositions to treat conditions associated with neovascularization
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2001247471A1 (en) Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2001242130A1 (en) Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
AU2002363935A1 (en) Composition and method for the treatment of anorectal disorders
AU2002360531A1 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2002366809A1 (en) Syn3 compositions and methods
AUPQ872800A0 (en) Compositions and methods for treating cardiovascular disorders
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
EP1315499A4 (fr) Compositions et methodes destinees au traitement des troubles anorectaux
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease